Amneal Pharmaceuticals (AMRX) Current Ratio: History & Chart

Amneal Pharmaceuticals, Inc.(AMRX)

Drug Manufacturers - Specialty & Generic · Bridgewater, NJ

$20.41+0.06 (+0.29%)

Delayed quote: Oct 6, 2026, 12:25 PM EDT

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications, topical applications, softgels, inhalants, and transdermal patches, all catering to a broad spectrum of medical needs. Within the Specialty division, the company concentrates on the advancement, marketing, sales, and distribution of proprietary branded pharmaceuticals. Key therapeutic areas for this segment include neurological conditions, endocrine disorders, and parasitic ailments, among others. Notable offerings include Emverm, a chewable tablet prescribed for single or mixed parasitic infections such as pinworm and various hookworms; Rytary, designed for the management of Parkinson's disease; and Unithroid, used in treating hypothyroidism. The AvKARE segment primarily serves governmental entities, particularly the Department of Defense and the Department of Veterans Affairs, supplying them with pharmaceuticals, medical and surgical supplies, and related services. Additionally, this segment engages in the bulk distribution of bottled and unit-dose pharmaceuticals under its AvKARE and AvPAK brands, alongside medical and surgical items. It also manages the packaging and large-scale distribution of medications and nutritional supplements for its retail and institutional clientele. Products from Amneal reach consumers through a network comprising wholesale suppliers, third-party distributors, hospitals, large pharmacy chains, and independent drugstores. Its operational footprint extends across the United States, India, Ireland, and other international markets. Established in 2002, the company was initially incorporated as Atlas Holdings, Inc., before adopting the name Amneal Pharmaceuticals, Inc. in 2018. Its corporate headquarters are situated in Bridgewater, New Jersey.

Bridgewater, NJ

8,700 employees

www.amneal.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Chirag K. Patel

View full financials

AMRX Current Ratio Metrics

CURRENT RATIO

2.20

CURRENT RATIO AVG TTM

2.08

CURRENT RATIO AVG 3Y

1.77

CURRENT RATIO AVG 5Y

1.87

CURRENT RATIO AVG 10Y

2.05

CURRENT RATIO AVG 15Y

N/A

CURRENT RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+5.93%

CURRENT VS 3Y AVG

+24.85%

CURRENT VS 5Y AVG

+18.05%

CURRENT VS 10Y AVG

+7.46%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.59

median of 750 covered companies

CURRENT VS SECTOR MEDIAN

-38.68%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Amneal Pharmaceuticals, Inc. (AMRX)	$6.52B	2.20	2.08	1.77	1.87
Lantheus Holdings, Inc. (LNTH)vs ›	$6.51B	3.06	4.11	4.19	3.61
Hims & Hers Health, Inc. (HIMS)vs ›	$6.53B	0.93	1.84	2.80	3.67
Rhythm Pharmaceuticals, Inc. (RYTM)vs ›	$6.36B	3.45	3.83	5.53	6.55
Immunovant, Inc. (IMVT)vs ›	$6.63B	7.27	10.13	10.82	12.77
Chemed Corporation (CHE)vs ›	$6.67B	0.91	1.21	1.24	1.14
GRAIL Inc. (GRAL)vs ›	$5.94B	10.95	11.32	6.44	5.89
Alkermes plc (ALKS)vs ›	$7.04B	2.30	3.29	2.93	2.75
Ligand Pharmaceuticals Incorporated (LGND)vs ›	$5.95B	31.18	15.58	12.00	10.69
Iovance Biotherapeutics, Inc. (IOVA)vs ›	$5.87B	4.35	3.47	3.74	5.38

NAME

MARKET CAP

CURRENT RATIO

TTM

Amneal Pharmaceuticals, Inc. (AMRX)

$6.52B

2.20

2.08

1.77

1.87

Lantheus Holdings, Inc. (LNTH)vs ›

$6.51B

3.06

4.11

4.19

3.61

Hims & Hers Health, Inc. (HIMS)vs ›

$6.53B

0.93

1.84

2.80

3.67

Rhythm Pharmaceuticals, Inc. (RYTM)vs ›

$6.36B

3.45

3.83

5.53

6.55

Immunovant, Inc. (IMVT)vs ›

$6.63B

7.27

10.13

10.82

12.77

Chemed Corporation (CHE)vs ›

$6.67B

0.91

1.21

1.24

1.14

GRAIL Inc. (GRAL)vs ›

$5.94B

10.95

11.32

6.44

5.89

Alkermes plc (ALKS)vs ›

$7.04B

2.30

3.29

2.93

2.75

Ligand Pharmaceuticals Incorporated (LGND)vs ›

$5.95B

31.18

15.58

12.00

10.69

Iovance Biotherapeutics, Inc. (IOVA)vs ›

$5.87B

4.35

3.47

3.74

5.38

Current Ratio FAQ

What is the current ratio for Amneal Pharmaceuticals, Inc. (AMRX)?

The current ratio for AMRX stock is 2.20.

Is Amneal Pharmaceuticals, Inc.'s current ratio high or low?

The current ratio of 2.20 is 18% above its 5-year average of 1.87, near the high end of its 5-year range (1.33–2.47).

What is the TTM average current ratio for Amneal Pharmaceuticals, Inc. (AMRX)?

The TTM average current ratio for AMRX stock is 2.08.

What is the 3Y average current ratio for Amneal Pharmaceuticals, Inc. (AMRX)?

The 3Y average current ratio for AMRX stock is 1.77.

What is the 5Y average current ratio for Amneal Pharmaceuticals, Inc. (AMRX)?

The 5Y average current ratio for AMRX stock is 1.87.

What is the 10Y average current ratio for Amneal Pharmaceuticals, Inc. (AMRX)?

The 10Y average current ratio for AMRX stock is 2.05.

DATE	CURRENT RATIO
2026-06-30	2.20
2026-03-31	2.47
2025-12-31	2.17
2025-09-30	2.13
2025-06-30	1.43
2025-03-31	1.40
2024-12-31	1.41
2024-09-30	1.38
2024-06-30	1.33
2024-03-31	1.65
2023-12-31	1.63
2023-09-30	1.91
2023-06-30	1.83
2023-03-31	1.86
2022-12-31	1.88
2022-09-30	1.74
2022-06-30	1.56
2022-03-31	2.31
2021-12-31	2.24
2021-09-30	2.35
2021-06-30	2.32
2021-03-31	2.45
2020-12-31	2.29
2020-09-30	2.31
2020-06-30	2.26
2020-03-31	1.84
2019-12-31	2.20
2019-09-30	2.25
2019-06-30	2.17
2019-03-31	2.11
2018-12-31	2.32
2018-09-30	1.91
2018-06-30	2.01
2018-03-31	0.15
2017-12-31	2.60
2017-09-30	2.68
2017-06-30	0.00
2017-03-31	0.00
2016-12-31	3.23

DATE

CURRENT RATIO

2026-06-30

2.20

2026-03-31

2.47

2025-12-31

2.17

2025-09-30

2.13

2025-06-30

1.43

2025-03-31

1.40

2024-12-31

1.41

2024-09-30

1.38

2024-06-30

1.33

2024-03-31

1.65

2023-12-31

1.63

2023-09-30

1.91

2023-06-30

1.83

2023-03-31

1.86

2022-12-31

1.88

2022-09-30

1.74

2022-06-30

1.56

2022-03-31

2.31

2021-12-31

2.24

2021-09-30

2.35

2021-06-30

2.32

2021-03-31

2.45

2020-12-31

2.29

2020-09-30

2.31

2020-06-30

2.26

2020-03-31

1.84

2019-12-31

2.20

2019-09-30

2.25

2019-06-30

2.17

2019-03-31

2.11

2018-12-31

2.32

2018-09-30

1.91

2018-06-30

2.01

2018-03-31

0.15

2017-12-31

2.60

2017-09-30

2.68

2017-06-30

0.00

2017-03-31

0.00

2016-12-31

3.23

Current Ratio: 2.20

AMRX Current Ratio

AMRX Average Current Ratio Chart

AMRX Current vs Average Current Ratio Chart

AMRX Current Ratio Metrics

AMRX Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

AMRX Current Ratio History

Related Metrics